NCT02428283View on ClinicalTrials.gov

Scalp Nerve Block on Emergence Agitation

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Agitation
Interventions
DRUG

Ropivacaine

0.25% ropivacaine 2-3 ml was injected around the scalp nerves that are located on the head.

DRUG

Remifentanil

Remifentanil 1 μg/kg was injected before skin incision.

DRUG

Sevoflurane

Anesthesia was titrated with sevoflurane, maintaining mean arterial pressure and heart rate within 20% baseline value.

Trial Locations (1)

443-721

Ajou University Hospital, Suwon

All Listed Sponsors
lead

Ajou University School of Medicine

OTHER

NCT02428283 - Scalp Nerve Block on Emergence Agitation | Biotech Hunter | Biotech Hunter